| Literature DB >> 30171731 |
Ademola Adetokunbo Oyagbemi1, Temidayo Olutayo Omobowale2, Olufunke Eunice Ola-Davies1, Ebunoluwa Racheal Asenuga3, Temitayo Olabisi Ajibade1, Olumuyiwa Abiola Adejumobi2, Oluwatosin Adetola Arojojoye4, Jeremiah Moyinoluwa Afolabi2,5, Blessing Seun Ogunpolu2, Olufunke Olubunmi Falayi6, Fasilat Oluwakemi Hassan1, Grace Onyeche Ochigbo6, Adebowale Benard Saba6, Adeolu Alex Adedapo6, Momoh Audu Yakubu7.
Abstract
Hypertension is one of the silent killers in the world with high mortality and morbidity. The exposure of humans and animals to fluoride and/or fluoride containing compounds is almost inevitable. This study investigated the modulatory effects of quercetin on sodium fluoride (NaF)-induced hypertension and cardiovascular complications. Forty male rats were randomly separated into four groups (n =10). Group A animals served as the control, rats in Group B were exposed to 300 ppm of NaF, Groups C and D animals were exposed to 300 ppm of NaF along with quercetin orally at 50 mg/kg and 100 mg/kg orally by gavage, while NaF was administered in drinking water, respectively, for a week. Administration of NaF caused severe hypertension as indicated with significant increases in the systolic, diastolic, and mean arterial blood pressure, together with prolonged ventricular depolarization (QRS) and the time between the start of the Q wave and the end of the T wave in the heart's electrical cycle (QT) intervals when compared with controls. NaF significantly decreased the activities of antioxidant enzymes, caused increase in markers of oxidative stress and renal damage when compared with controls. Immunohistochemical staining revealed lower expressions of Hsp70, ERK, and PPARγ in the heart, kidney, and aorta of rats-administered NaF relative to the controls. Together, quercetin co-treatment with NaF restored blood pressure, normalized QRS interval, and improved antioxidant defense system.Entities:
Keywords: hypertension; nutraceutical; oxidative stress; quercetin; sodium fluoride
Mesh:
Substances:
Year: 2018 PMID: 30171731 DOI: 10.1002/biof.1445
Source DB: PubMed Journal: Biofactors ISSN: 0951-6433 Impact factor: 6.113